ACTA1 and renal fibrosis: Both treatments significantly reduced the expression levels of COL-I, FN, and α-SMA, suggesting their potential to inhibit extracellular matrix accumulation and epithelial-mesenchymal transition processes, these results indicated that WYJDTLF could attenuate the degree of renal fibrosis in db/db mice.